Zhenhai Yu

1.8k total citations
46 papers, 1.3k citations indexed

About

Zhenhai Yu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Zhenhai Yu has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Zhenhai Yu's work include Peptidase Inhibition and Analysis (12 papers), Cancer Mechanisms and Therapy (12 papers) and Endometriosis Research and Treatment (11 papers). Zhenhai Yu is often cited by papers focused on Peptidase Inhibition and Analysis (12 papers), Cancer Mechanisms and Therapy (12 papers) and Endometriosis Research and Treatment (11 papers). Zhenhai Yu collaborates with scholars based in China, Japan and United States. Zhenhai Yu's co-authors include Chune Ren, Pengyun Qiao, Tingting Yang, Xue Han, Yonghong Sun, Chao Lü, Li Wang, Shijun Lv, Liangqian Huang and Yu Du and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Zhenhai Yu

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenhai Yu China 24 751 451 274 237 199 46 1.3k
Chune Ren China 23 556 0.7× 360 0.8× 180 0.7× 324 1.4× 261 1.3× 41 1.2k
Shulan Zhang China 25 851 1.1× 358 0.8× 332 1.2× 457 1.9× 185 0.9× 96 1.7k
Oliver Treeck Germany 25 734 1.0× 340 0.8× 543 2.0× 181 0.8× 289 1.5× 87 1.7k
Youji Feng China 29 1.2k 1.6× 506 1.1× 496 1.8× 217 0.9× 388 1.9× 56 1.9k
Ruixia Guo China 20 970 1.3× 673 1.5× 287 1.0× 161 0.7× 140 0.7× 90 1.6k
Peishu Liu China 22 774 1.0× 473 1.0× 169 0.6× 131 0.6× 116 0.6× 62 1.2k
Ashwini L. Chand Australia 22 753 1.0× 242 0.5× 566 2.1× 329 1.4× 219 1.1× 41 1.6k
Michihiro Tanikawa Japan 19 534 0.7× 186 0.4× 244 0.9× 135 0.6× 204 1.0× 68 1.1k
Claus Lattrich Germany 18 355 0.5× 328 0.7× 508 1.9× 81 0.3× 155 0.8× 49 1.1k
Tsunekazu Kita Japan 24 876 1.2× 222 0.5× 433 1.6× 137 0.6× 505 2.5× 89 1.8k

Countries citing papers authored by Zhenhai Yu

Since Specialization
Citations

This map shows the geographic impact of Zhenhai Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenhai Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenhai Yu more than expected).

Fields of papers citing papers by Zhenhai Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenhai Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenhai Yu. The network helps show where Zhenhai Yu may publish in the future.

Co-authorship network of co-authors of Zhenhai Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenhai Yu. A scholar is included among the top collaborators of Zhenhai Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenhai Yu. Zhenhai Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lan, et al.. (2025). AARS1 promotes endometriosis progression by promoting the lactylation of Snail1. Biology of Reproduction. 113(5). 1209–1218.
2.
Yu, Lianbo, Lijuan Kang, Songtao Xue, et al.. (2024). 807MO High efficacy and safety of interleukin-6-knockdown CD19-targeted CAR-T cells in relapsed/refractory B-ALL patients. Annals of Oncology. 35. S599–S599. 1 indexed citations
3.
Yu, Zhenhai, Shuo Zhang, Caihua Liu, et al.. (2024). Enzymatic hydrolysis pretreatment combined with glycosylation for soybean protein isolate applying in dual-protein yogurt. Food Chemistry X. 24. 101837–101837. 3 indexed citations
4.
Wang, Mengxue, Ruiqi Fan, Junyi Jiang, et al.. (2023). PIM2 Promotes the Development of Ovarian Endometriosis by Enhancing Glycolysis and Fibrosis. Reproductive Sciences. 30(9). 2692–2702. 12 indexed citations
5.
Li, Minjing, Yue Yu, Xiang Li, et al.. (2023). DNAJC10 maintains survival and self-renewal of leukemia stem cells through PERK branch of the unfolded protein response. Haematologica. 109(3). 751–764. 5 indexed citations
6.
Han, Xue, Chune Ren, Chao Lü, et al.. (2022). Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis. Cell Death and Differentiation. 29(9). 1864–1873. 63 indexed citations
7.
Wang, Mengxue, Pengyun Qiao, Aifang Jiang, et al.. (2022). CHIP induces ubiquitination and degradation of HMGB1 to regulate glycolysis in ovarian endometriosis. Cellular and Molecular Life Sciences. 80(1). 13–13. 19 indexed citations
8.
Wang, Yixin, et al.. (2021). HSF1 promotes endometriosis development and glycolysis by up-regulating PFKFB3 expression. Reproductive Biology and Endocrinology. 19(1). 86–86. 23 indexed citations
9.
Lü, Chao, Chune Ren, Tingting Yang, et al.. (2020). A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer. Molecular Cancer Research. 18(5). 787–796. 24 indexed citations
10.
Lü, Chao, Chune Ren, Tingting Yang, et al.. (2020). Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation. Theranostics. 10(19). 8606–8618. 19 indexed citations
11.
Yang, Tingting, Chune Ren, Chao Lü, et al.. (2019). Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer. Cancer Research. 79(20). 5233–5244. 72 indexed citations
12.
Yang, Tingting, Chune Ren, Pengyun Qiao, et al.. (2019). Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer. Oncogene. 39(3). 720–721. 85 indexed citations
13.
Han, Xue, Chune Ren, Tingting Yang, et al.. (2019). Negative regulation of AMPKα1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer. Oncogene. 38(38). 6537–6549. 33 indexed citations
14.
Yu, Zhenhai, Liangqian Huang, Pengyun Qiao, et al.. (2016). PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells. Biochemical and Biophysical Research Communications. 473(4). 953–958. 31 indexed citations
15.
Zhou, Xiang, Ruohua Chen, Zhenhai Yu, et al.. (2015). Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation. Molecular Cancer. 14(1). 63–63. 52 indexed citations
16.
Chen, Ruohua, Xiang Zhou, Zhenhai Yu, Jianjun Liu, & Gang Huang. (2015). Low Expression of LDHB Correlates With Unfavorable Survival in Hepatocellular Carcinoma. Medicine. 94(39). e1583–e1583. 26 indexed citations
17.
Yu, Zhenhai, Yingying Ge, Lei Xie, et al.. (2014). Using a yeast two-hybrid system to identify FTCD as a new regulator for HIF-1α in HepG2 cells. Cellular Signalling. 26(7). 1560–1566. 18 indexed citations
18.
Huang, Liangqian, Zhenhai Yu, Teng Zhang, Xiaoping Zhao, & Gang Huang. (2014). HSP40 Interacts with Pyruvate Kinase M2 and Regulates Glycolysis and Cell Proliferation in Tumor Cells. PLoS ONE. 9(3). e92949–e92949. 37 indexed citations
19.
Yu, Zhenhai, Xiaoping Zhao, Liangqian Huang, et al.. (2013). Proviral Insertion in Murine Lymphomas 2 (PIM2) Oncogene Phosphorylates Pyruvate Kinase M2 (PKM2) and Promotes Glycolysis in Cancer Cells. Journal of Biological Chemistry. 288(49). 35406–35416. 78 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chune Ren Breakdown of academic impact, for papers by Shulan Zhang Breakdown of academic impact, for papers by Oliver Treeck Breakdown of academic impact, for papers by Youji Feng Breakdown of academic impact, for papers by Ruixia Guo Breakdown of academic impact, for papers by Peishu Liu Breakdown of academic impact, for papers by Ashwini L. Chand Breakdown of academic impact, for papers by Michihiro Tanikawa Breakdown of academic impact, for papers by Claus Lattrich Breakdown of academic impact, for papers by Tsunekazu Kita
Rankless by CCL
2026